{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:19:21Z","timestamp":1783171161003,"version":"3.54.6"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016421","name":"Cardiovascular Medical Research and Education Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R43HL169134"],"award-info":[{"award-number":["R43HL169134"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL144590"],"award-info":[{"award-number":["R01HL144590"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.molmed.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:14:02Z","timestamp":1777896842000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the NAD+\u2013PARP1\u2013XRCC1 axis in ALS"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-1500","authenticated-orcid":false,"given":"Md","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Shahadat","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lezanne","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mahmudul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandra","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasger K.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhrul","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.04.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.molmed.2026.04.004_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-019-0874-4","article-title":"DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations","volume":"8","author":"Kim","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.molmed.2026.04.004_bb0020","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1093\/brain\/awad120","article-title":"Genetic variability in sporadic amyotrophic lateral sclerosis","volume":"146","author":"van Daele","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2026.04.004_bb0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jmedgenet-2021-107965","article-title":"Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population","volume":"59","author":"Chen","year":"2022","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2026.04.004_bb0030","doi-asserted-by":"crossref","first-page":"E7701","DOI":"10.1073\/pnas.1611673113","article-title":"Two familial ALS proteins function in prevention\/repair of transcription-associated DNA damage","volume":"113","author":"Hill","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.04.004_bb0035","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nn.3514","article-title":"Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons","volume":"16","author":"Wang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2026.04.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi5548","article-title":"Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import","volume":"9","author":"Mann","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2026.04.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101025","article-title":"The scaffold protein XRCC1 stabilizes the formation of pol\u03b2\/gap DNA and ligase III\u03b1\/nick DNA complexes in base excision repair","volume":"297","author":"Tang","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2026.04.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109917","article-title":"Temporal dynamics of base excision\/single-strand break repair protein complex assembly\/disassembly are modulated by the PARP\/NAD+\/SIRT6 axis","volume":"37","author":"Koczor","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2023.103452","article-title":"Pol\u03b2\/XRCC1 heterodimerization dictates DNA damage recognition and basal Pol\u03b2 protein levels without interfering with mouse viability or fertility","volume":"123","author":"Koczor","year":"2023","journal-title":"DNA Repair"},{"key":"10.1016\/j.molmed.2026.04.004_bb0060","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.molcel.2021.05.009","article-title":"XRCC1 prevents toxic PARP1 trapping during DNA base excision repair","volume":"81","author":"Demin","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41556-021-00792-w","article-title":"XRCC1 protects transcription from toxic PARP1 activity during DNA base excision repair","volume":"23","author":"Adamowicz","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0070","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1093\/nar\/gkac695","article-title":"Processing oxidatively damaged bases at DNA strand breaks by APE1","volume":"50","author":"Whitaker","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0075","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1093\/nar\/gkab618","article-title":"Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose)","volume":"49","author":"Reber","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113199","article-title":"FUS RRM regulates poly(ADP-ribose) levels after transcriptional arrest and PARP-1 activation on DNA damage","volume":"42","author":"Mamontova","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf086","article-title":"XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites","volume":"53","author":"Lin","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0090","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1038\/s41467-024-50912-x","article-title":"PARP1-dependent DNA-protein crosslink repair","volume":"15","author":"F\u00e1bi\u00e1n","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.04.004_bb0095","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1016\/j.molcel.2021.10.026","article-title":"Parp1 promotes sleep, which enhances DNA repair in neurons","volume":"81","author":"Zada","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.04.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105077","article-title":"PARP-1 activation leads to cytosolic accumulation of TDP-43 in neurons","volume":"148","author":"Marcus","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.molmed.2026.04.004_bb0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-018-0586-1","article-title":"Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis","volume":"6","author":"McGurk","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.molmed.2026.04.004_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature12504","article-title":"Topoisomerases facilitate transcription of long genes linked to autism","volume":"501","author":"King","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.04.004_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2024.12.001","article-title":"DNA damage and its links to neuronal aging and degeneration","volume":"113","author":"Delint-Ramirez","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2026.04.004_bb0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuron.2014.06.034","article-title":"DNA damage and its links to neurodegeneration","volume":"83","author":"Madabhushi","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2026.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.molcel.2020.12.039","article-title":"Single-strand DNA breaks cause replisome disassembly","volume":"81","author":"Vrtis","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.04.004_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tibs.2023.11.001","article-title":"Causes and consequences of DNA single-strand breaks","volume":"49","author":"Caldecott","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molmed.2026.04.004_bb0135","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1\u2013dependent cell death (parthanatos)","volume":"4","author":"Wang","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molmed.2026.04.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114626","article-title":"ALS-FUS mutations cause abnormal PARylation and histone H1.2 interaction, leading to pathological changes","volume":"43","author":"Alirzayeva","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature20790","article-title":"XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia","volume":"541","author":"Hoch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.04.004_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104714","article-title":"Functional analysis of a conserved site mutation in the DNA end processing enzyme PNKP leading to ataxia with oculomotor apraxia type 4 in humans","volume":"299","author":"Islam","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2026.04.004_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.04.004_bb0160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0165","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154217","article-title":"Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease","volume":"23","author":"Welch","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2006.07.044","article-title":"AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS","volume":"406","author":"Oh","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2026.04.004_bb0175","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.celrep.2019.04.031","article-title":"PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA","volume":"27","author":"Singatulina","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0180","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization","volume":"71","author":"McGurk","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.04.004_bb0185","article-title":"Selective inhibition of cytosolic PARylation via PARG99: a targeted approach for mitigating FUS-associated neurodegeneration","author":"Kodavati","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2026.04.004_bb0190","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","article-title":"The NAD+\/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling","volume":"154","author":"Mouchiroud","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.04.004_bb0195","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/jnnp-2020-323611","article-title":"Untargeted metabolomics yields insight into ALS disease mechanisms","volume":"91","author":"Goutman","year":"2020","journal-title":"J. Neurol. Neurosurg."},{"key":"10.1016\/j.molmed.2026.04.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113219","article-title":"Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models","volume":"327","author":"Harlan","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11306-011-0306-3","article-title":"Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis","volume":"8","author":"Noga","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.molmed.2026.04.004_bb0210","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival","volume":"30","author":"Murata","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2026.04.004_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00511-x","article-title":"Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients","volume":"17","author":"Bloom","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.molmed.2026.04.004_bb0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70905","article-title":"Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders","volume":"10","author":"Gilley","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2026.04.004_bb0225","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2021.03.021","article-title":"An NAD+\/NMN balancing act by SARM1 and NMNAT2 controls axonal degeneration","volume":"109","author":"Waller","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2026.04.004_bb0230","article-title":"SARM1 is an essential component of neuronal parthanatos","author":"Wu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2026.04.004_bb0235","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s12035-020-02188-7","article-title":"Nicotinamide riboside and pterostilbene cooperatively delay motor neuron failure in ALS SOD1G93A mice","volume":"58","author":"Obrador","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0240","article-title":"Astrocyte metabolism and signaling pathways in the CNS","volume":"17","author":"Zhang","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.molmed.2026.04.004_bb0245","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1038\/s41467-018-06111-6","article-title":"Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in amyotrophic lateral sclerosis","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.04.004_bb0250","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1021\/acs.jpcb.4c04663","article-title":"The effect of dipeptide repeat proteins on FUS\/TDP43-RNA condensation in C9orf72 ALS\/FTD","volume":"128","author":"Driver","year":"2024","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.molmed.2026.04.004_bb0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/hmg\/ddad163","article-title":"Disrupted phase behavior of FUS underlies poly-PR-induced DNA damage in amyotrophic lateral sclerosis","volume":"33","author":"Wang","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2026.04.004_bb0260","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0265","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.neuron.2022.02.010","article-title":"Excessive release of inorganic polyphosphate by ALS\/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons","volume":"110","author":"Arredondo","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2026.04.004_bb0270","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.4049\/jimmunol.174.4.2288","article-title":"Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death","volume":"174","author":"Kauppinen","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109695","article-title":"PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination","volume":"37","author":"Wang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104351","article-title":"Pathogenic TDP-43 in amyotrophic lateral sclerosis","volume":"30","author":"Chong","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2026.04.004_bb0285","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1093\/nar\/gkaa718","article-title":"Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo","volume":"48","author":"Shao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nar\/gkt835","article-title":"PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS\/TLS to sites of oxidative DNA damage","volume":"42","author":"Rulten","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0295","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11060-023-04514-0","article-title":"A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)","volume":"165","author":"Kleinberg","year":"2023","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116405","article-title":"High affinity and low PARP-trapping benzimidazole derivatives as a potential warhead for PARP1 degraders","volume":"271","author":"Peng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molmed.2026.04.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027421","article-title":"Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis","volume":"100","author":"Henderson","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.molmed.2026.04.004_bb0310","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molmet.2019.09.013","article-title":"A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor","volume":"30","author":"Giroud-Gerbetant","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104521","article-title":"Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers","volume":"90","author":"Dorst","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2026.04.004_bb0320","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/18796397251372667","article-title":"Tipping the PARylation scale: dysregulation of PAR signaling in Huntington and neurodegenerative diseases","volume":"14","author":"Peng","year":"2025","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.molmed.2026.04.004_bb0325","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/biomedicines9081000","article-title":"NAD+ precursors and antioxidants for the treatment of amyotrophic lateral sclerosis","volume":"9","author":"Obrador","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.molmed.2026.04.004_bb0330","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1093\/hmg\/ddac116","article-title":"Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS","volume":"31","author":"Tossing","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2026.04.004_bb0335","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1158\/1078-0432.CCR-17-1121","article-title":"Matrix screen identifies synergistic combination of PARP inhibitors and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors in Ewing sarcoma","volume":"23","author":"Heske","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0340","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2026.04.004_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.04.004_bb0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","article-title":"Poly(ADP-ribose) polymerase inhibition: past, present and future","volume":"19","author":"Curtin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2026.04.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117770","article-title":"The PARG frontier: mechanisms of PAR turnover and opportunities in precision oncology","volume":"247","author":"Catara","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0360","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41598-020-57506-9","article-title":"Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity","volume":"10","author":"Wilk","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2026.04.004_bb0365","article-title":"NAD+ bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells. NAR","volume":"3","author":"Li","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.molmed.2026.04.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102131","article-title":"Anti-miRNA103\/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage","volume":"35","author":"Cepparulo","year":"2024","journal-title":"Mol. Ther. Nucleic. Acids"},{"key":"10.1016\/j.molmed.2026.04.004_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417097","article-title":"Lipid nanoparticles enhance mRNA delivery to the central nervous system upon intrathecal injection","volume":"37","author":"Xue","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.molmed.2026.04.004_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2026.04.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molmed.2026.04.004_bb0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41592-020-01010-5","article-title":"Deciphering molecular interactions by proximity labeling","volume":"18","author":"Qin","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2026.04.004_bb0395","article-title":"Replication-associated base excision repair\/single-strand break repair regulates PARG inhibitor response via the PRMT1\/PRMT5\/ATR axis. NAR","volume":"7","author":"Ibrahim","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.molmed.2026.04.004_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110501","article-title":"Proximity labeling techniques for protein\u2013protein interaction mapping in plants","volume":"301","author":"\u00d6zmen","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2026.04.004_bb0405","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41401-021-00852-9","article-title":"Current strategies and progress for targeting the \u2018undruggable\u2019 transcription factors","volume":"43","author":"Zhuang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molmed.2026.04.004_bb0410","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle\u2013mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.molmed.2026.04.004_bb0415","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14728222.2020.1738390","article-title":"Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)","volume":"24","author":"Abati","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.molmed.2026.04.004_bb0420","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1021\/acs.chemrev.2c00851","article-title":"Regulation of biomolecular condensates by Poly(ADP-ribose)","volume":"123","author":"Rhine","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molmed.2026.04.004_bb0425","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13041-019-0526-4","article-title":"RT2 PCR array screening reveals distinct perturbations in DNA damage response signaling in FUS-associated motor neuron disease","volume":"12","author":"Wang","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.molmed.2026.04.004_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.637548","article-title":"Emerging perspectives on dipeptide repeat proteins in C9ORF72 ALS\/FTD","volume":"15","author":"Schmitz","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2026.04.004_bb0435","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41467-024-45978-6","article-title":"FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease","volume":"15","author":"Kodavati","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.04.004_bb0440","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jamaneurol.2025.4946","article-title":"Long-term tofersen in SOD1 amyotrophic lateral sclerosis","volume":"83","author":"Miller","year":"2026","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.molmed.2026.04.004_bb0445","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/biom14121556","article-title":"Pathobiochemistry of aging and neurodegeneration: deregulation of NAD+ metabolism in brain cells","volume":"14","author":"Kolotyeva","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2026.04.004_bb0450","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","article-title":"Frameworks for transformational breakthroughs in RNA-based medicines","volume":"23","author":"Androsavich","year":"2024","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:33:50Z","timestamp":1783168430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":90,"alternative-id":["S1471491426000869"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.04.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the NAD+\u2013PARP1\u2013XRCC1 axis in ALS","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}